Wedge Industrial (000534) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Revenue for H1 2024 reached ¥502.75 million, up 5.72% year-over-year; net profit attributable to shareholders was ¥97.99 million, up 12.49% year-over-year.
Main businesses include microecological active bacteria products and high-temperature alloy R&D, production, and sales.
The company continued to optimize cost management and enhance profitability amid operational pressures.
Financial highlights
Operating income: ¥502.75 million (+5.72% YoY); net profit attributable to shareholders: ¥97.99 million (+12.49% YoY).
Net profit excluding non-recurring items: ¥85.31 million (+11.01% YoY).
Basic EPS: ¥0.1975 (+14.43% YoY); diluted EPS: ¥0.1922 (+12.60% YoY).
Operating cash flow: ¥2.83 million (+31.02% YoY).
Total assets at period end: ¥3.33 billion (+6.76% from year-end 2023); net assets attributable to shareholders: ¥1.15 billion (-5.20%).
Gross margin for key products: '金双歧' 88.00%, '定君生' 90.89%.
Outlook and guidance
The company will continue to focus on microecological and high-temperature alloy businesses, leveraging national policy support and stable cash flow from core operations to drive growth.
No interim dividend, bonus shares, or capital increase from reserves planned for H1 2024.
Latest events from Wedge Industrial
- Q3 2024 saw double-digit profit growth, robust cash flow, and major investments in expansion.000534
Q3 20249 Jul 2026 - Audit confirms accurate related party fund flows and significant intra-group transactions in 2024.000534
Q4 20249 Jul 2026 - Revenue and profit surged, with robust growth in pharma and alloy businesses and strategic investments.000534
Q2 20259 Jul 2026 - Revenue and net profit rose over 10% year-over-year, with robust growth in high-temperature alloys.000534
Q1 20259 Jul 2026 - Revenue and profit surged over 20% year-over-year, led by high-temperature alloy sales.000534
Q3 20259 Jul 2026 - Revenue up 19.62% to ¥1.29B, net profit up 2.22%, with strong R&D and no cash dividend.000534
Q4 20259 Jul 2026 - Q1 2026 saw revenue and profit growth, negative cash flow, and major strategic investment in a subsidiary.000534
Q1 20269 Jul 2026